The researchers concluded: The GLP-1 analogue semaglutide decreased alcohol intake across different drinking models and species and modulated central GABA neurotransmission, providing support for clinical testing of semaglutide as a potentially novel pharmacotherapy for AUD. Dr Leggio told CNN drugs like semaglutide may influence interest in things like alcohol because they have an effect not just in the gut, but in the brain
Aguirre, V
Obesity and high blood pressure are closely related chronic health conditions that are of growing concern globally
Food and Drug Administration (FDA) DailyMed Label: Bacteriostatic Water for Injection (Provides official labeling, storage instructions, and preservative information) United States Pharmacopeia (USP) USPNF General Chapters & Monographs (Defines standards for sterile water for injection and pharmaceutical quality requirements) World Health Organization (WHO) WHO Good Storage and Distribution Practices (Guidelines for temperature control, sterility, and pharmaceutical handling) American Society of Health-System Pharmacists (ASHP) (Clinical guidance on sterile product handling and multi-dose vial use) FDA Guidance on Sterile Drug Products (Aseptic handling, contamination risk, and storage principles)
Active ingredient: minimum 1.0%
Safety data in humans is limited, and therapy should only be considered under licensed medical supervision though research is still ongoing